GN has signed an agreement to divest BelAudição to MCH Private Equity. BelAudição is the owner of the leading retailer of hearing aid solutions in Portugal, AudiçãoActiva, with around 50 hearing...
La operación, que se ha cerrado a partir de fondos propios, tiene como objetivo la creación de sinergias entre ambos equipos para asumir nuevos retos de negocio: convertirse en la empresa de referen...
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in Montreal-based liV Inc. (liV), a provider of evidence-based medical education services...
UNAVETS Group is a leading veterinary group with over 100 centres in Iberia. UNAVETS is a network of reference/specialist centres, 24-hour hospitals, primary opinion clinics and veterinary practices w...
Tras la lucha contra el Covid-19, las farmacéuticas se enfrentan a una nueva normalidad repleta de oportunidades y desafíos, y el mercado está listo para aprovecharlas. El reciente anuncio de que E...
Arcano Partners ha asesorado a Grupo SSG en la venta de una participación mayoritaria a Asterion Industrial Partners. Esta transacción permitirá a la compañía impulsar su plan de crecimiento naci...
Palex is the leading provider of high value-added medical technology (“MedTech”) equipment and solutions in Southern Europe. Following the transaction, Apax and Fremman will partner with Palex’s...
El fondo de capital de riesgo español MCH Private Equity se ha incorporado al accionario de la compañía de especialidades farmacéuticas con el objetivo de impulsar a la empresa madrileña en el me...
Asabys Partners led the round through its new fund Sabadell Asabys II and was joined by Thuja Capital and founding investor Sofinnova Partners. Gradient was established in 2020 through a €3.5m seed ...
The round was led by Philips Ventures and XTX Ventures -the venture capital arm of leading algorithmic trading company XTX Markets-. Fondo Bolsa Social and Redseed also participated in the round, as w...
AbolerIS Pharma, a Belgian biopharmaceutical company developing an entirely novel approach to the treatment of chronic autoimmune and inflammatory diseases, today announced a €27.3 million Series A ...
Aliath Bioventures, the healthcare impact investment platform of AltamarCAM Partners, appoints Philippe Monteyne, MD, PhD as a new Partner to reinforce the company’s healthcare investment team.